世界の神経疾患治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Neurologic Disorders Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4568 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、神経疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（中枢神経系（CNS）、末梢神経系（PNS））、用途別市場規模（麻痺、筋力低下、協調運動不全、感覚喪失、発作、錯乱、疼痛、意識レベル変化）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・神経疾患治療薬の市場動向 ・企業の競争状況、市場シェア ・神経疾患治療薬の種類別市場規模と予測2016-2027（中枢神経系（CNS）、末梢神経系（PNS）） ・神経疾患治療薬の用途別市場規模と予測2016-2027（麻痺、筋力低下、協調運動不全、感覚喪失、発作、錯乱、疼痛、意識レベル変化） ・神経疾患治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・神経疾患治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・神経疾患治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・神経疾患治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・神経疾患治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biogen Inc.、F. Hoffmann-La Roche Ltd.、Johnson & Johnson Services Inc.、Novartis AG、Pfizer Inc.） ・結論

A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare.
The early diagnosis of neurodegenerative indications is difficult because of their complex nature, fast progression, and lack of effective diagnostic processes. This has encouraged researchers to focus on the development of novel biomarkers that can accurately detect neurodegenerative indications.

Market Analysis and Insights: Global Neurologic Disorders Therapeutics Market
The global Neurologic Disorders Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neurologic Disorders Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neurologic Disorders Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neurologic Disorders Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neurologic Disorders Therapeutics market.

Global Neurologic Disorders Therapeutics Scope and Market Size
Neurologic Disorders Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurologic Disorders Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Central Nervous System (CNS)
Peripheral Nervous System (PNS)

Segment by Application
Paralysis
Muscle Weakness
Poor Coordination
Loss of Sensation
Seizures
Confusion
Pain and Altered Levels of Consciousness

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biogen Inc.
F. Hoffmann-La Roche Ltd.
Johnson & Johnson Services Inc.
Novartis AG
Pfizer Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Central Nervous System (CNS)
1.2.3 Peripheral Nervous System (PNS)
1.3 Market by Application
1.3.1 Global Neurologic Disorders Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Paralysis
1.3.3 Muscle Weakness
1.3.4 Poor Coordination
1.3.5 Loss of Sensation
1.3.6 Seizures
1.3.7 Confusion
1.3.8 Pain and Altered Levels of Consciousness
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Neurologic Disorders Therapeutics Market Perspective (2016-2027)
2.2 Neurologic Disorders Therapeutics Growth Trends by Regions
2.2.1 Neurologic Disorders Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neurologic Disorders Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Neurologic Disorders Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Neurologic Disorders Therapeutics Industry Dynamic
2.3.1 Neurologic Disorders Therapeutics Market Trends
2.3.2 Neurologic Disorders Therapeutics Market Drivers
2.3.3 Neurologic Disorders Therapeutics Market Challenges
2.3.4 Neurologic Disorders Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Neurologic Disorders Therapeutics Players by Revenue
3.1.1 Global Top Neurologic Disorders Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Neurologic Disorders Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Neurologic Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neurologic Disorders Therapeutics Revenue
3.4 Global Neurologic Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Neurologic Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurologic Disorders Therapeutics Revenue in 2020
3.5 Neurologic Disorders Therapeutics Key Players Head office and Area Served
3.6 Key Players Neurologic Disorders Therapeutics Product Solution and Service
3.7 Date of Enter into Neurologic Disorders Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Neurologic Disorders Therapeutics Breakdown Data by Type
4.1 Global Neurologic Disorders Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Neurologic Disorders Therapeutics Forecasted Market Size by Type (2022-2027)

5 Neurologic Disorders Therapeutics Breakdown Data by Application
5.1 Global Neurologic Disorders Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Neurologic Disorders Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Neurologic Disorders Therapeutics Market Size (2016-2027)
6.2 North America Neurologic Disorders Therapeutics Market Size by Type
6.2.1 North America Neurologic Disorders Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Neurologic Disorders Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Neurologic Disorders Therapeutics Market Size by Type (2016-2027)
6.3 North America Neurologic Disorders Therapeutics Market Size by Application
6.3.1 North America Neurologic Disorders Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Neurologic Disorders Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Neurologic Disorders Therapeutics Market Size by Application (2016-2027)
6.4 North America Neurologic Disorders Therapeutics Market Size by Country
6.4.1 North America Neurologic Disorders Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Neurologic Disorders Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Neurologic Disorders Therapeutics Market Size (2016-2027)
7.2 Europe Neurologic Disorders Therapeutics Market Size by Type
7.2.1 Europe Neurologic Disorders Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Neurologic Disorders Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Neurologic Disorders Therapeutics Market Size by Type (2016-2027)
7.3 Europe Neurologic Disorders Therapeutics Market Size by Application
7.3.1 Europe Neurologic Disorders Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Neurologic Disorders Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Neurologic Disorders Therapeutics Market Size by Application (2016-2027)
7.4 Europe Neurologic Disorders Therapeutics Market Size by Country
7.4.1 Europe Neurologic Disorders Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Neurologic Disorders Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Neurologic Disorders Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Type
8.2.1 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Application
8.3.1 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region
8.4.1 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Neurologic Disorders Therapeutics Market Size (2016-2027)
9.2 Latin America Neurologic Disorders Therapeutics Market Size by Type
9.2.1 Latin America Neurologic Disorders Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Neurologic Disorders Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Neurologic Disorders Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Neurologic Disorders Therapeutics Market Size by Application
9.3.1 Latin America Neurologic Disorders Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Neurologic Disorders Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Neurologic Disorders Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Neurologic Disorders Therapeutics Market Size by Country
9.4.1 Latin America Neurologic Disorders Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Neurologic Disorders Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Neurologic Disorders Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type
10.2.1 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application
10.3.1 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country
10.4.1 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biogen Inc.
11.1.1 Biogen Inc. Company Details
11.1.2 Biogen Inc. Business Overview
11.1.3 Biogen Inc. Neurologic Disorders Therapeutics Introduction
11.1.4 Biogen Inc. Revenue in Neurologic Disorders Therapeutics Business (2016-2021)
11.1.5 Biogen Inc. Recent Development
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Details
11.2.2 F. Hoffmann-La Roche Ltd. Business Overview
11.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Ltd. Revenue in Neurologic Disorders Therapeutics Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Ltd. Recent Development
11.3 Johnson & Johnson Services Inc.
11.3.1 Johnson & Johnson Services Inc. Company Details
11.3.2 Johnson & Johnson Services Inc. Business Overview
11.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Introduction
11.3.4 Johnson & Johnson Services Inc. Revenue in Neurologic Disorders Therapeutics Business (2016-2021)
11.3.5 Johnson & Johnson Services Inc. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Neurologic Disorders Therapeutics Introduction
11.4.4 Novartis AG Revenue in Neurologic Disorders Therapeutics Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Introduction
11.5.4 Pfizer Inc. Revenue in Neurologic Disorders Therapeutics Business (2016-2021)
11.5.5 Pfizer Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Central Nervous System (CNS)
Table 3. Key Players of Peripheral Nervous System (PNS)
Table 4. Global Neurologic Disorders Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Neurologic Disorders Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Neurologic Disorders Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Neurologic Disorders Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Neurologic Disorders Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Neurologic Disorders Therapeutics Market Share by Regions (2022-2027)
Table 10. Neurologic Disorders Therapeutics Market Trends
Table 11. Neurologic Disorders Therapeutics Market Drivers
Table 12. Neurologic Disorders Therapeutics Market Challenges
Table 13. Neurologic Disorders Therapeutics Market Restraints
Table 14. Global Neurologic Disorders Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Neurologic Disorders Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Neurologic Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurologic Disorders Therapeutics as of 2020)
Table 17. Ranking of Global Top Neurologic Disorders Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Neurologic Disorders Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neurologic Disorders Therapeutics Product Solution and Service
Table 21. Date of Enter into Neurologic Disorders Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neurologic Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Neurologic Disorders Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Neurologic Disorders Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Neurologic Disorders Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Neurologic Disorders Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Neurologic Disorders Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Neurologic Disorders Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Neurologic Disorders Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Neurologic Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Neurologic Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Neurologic Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Neurologic Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Neurologic Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Neurologic Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Neurologic Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Neurologic Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Neurologic Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Neurologic Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Neurologic Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Neurologic Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Neurologic Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Neurologic Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Neurologic Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Neurologic Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Neurologic Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Neurologic Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Neurologic Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Neurologic Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Neurologic Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Neurologic Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Biogen Inc. Company Details
Table 62. Biogen Inc. Business Overview
Table 63. Biogen Inc. Neurologic Disorders Therapeutics Product
Table 64. Biogen Inc. Revenue in Neurologic Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Biogen Inc. Recent Development
Table 66. F. Hoffmann-La Roche Ltd. Company Details
Table 67. F. Hoffmann-La Roche Ltd. Business Overview
Table 68. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product
Table 69. F. Hoffmann-La Roche Ltd. Revenue in Neurologic Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 70. F. Hoffmann-La Roche Ltd. Recent Development
Table 71. Johnson & Johnson Services Inc. Company Details
Table 72. Johnson & Johnson Services Inc. Business Overview
Table 73. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product
Table 74. Johnson & Johnson Services Inc. Revenue in Neurologic Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Services Inc. Recent Development
Table 76. Novartis AG Company Details
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Neurologic Disorders Therapeutics Product
Table 79. Novartis AG Revenue in Neurologic Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Novartis AG Recent Development
Table 81. Pfizer Inc. Company Details
Table 82. Pfizer Inc. Business Overview
Table 83. Pfizer Inc. Neurologic Disorders Therapeutics Product
Table 84. Pfizer Inc. Revenue in Neurologic Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Pfizer Inc. Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurologic Disorders Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Central Nervous System (CNS) Features
Figure 3. Peripheral Nervous System (PNS) Features
Figure 4. Global Neurologic Disorders Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Paralysis Case Studies
Figure 6. Muscle Weakness Case Studies
Figure 7. Poor Coordination Case Studies
Figure 8. Loss of Sensation Case Studies
Figure 9. Seizures Case Studies
Figure 10. Confusion Case Studies
Figure 11. Pain and Altered Levels of Consciousness Case Studies
Figure 12. Neurologic Disorders Therapeutics Report Years Considered
Figure 13. Global Neurologic Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Neurologic Disorders Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Neurologic Disorders Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Neurologic Disorders Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Neurologic Disorders Therapeutics Market Share by Players in 2020
Figure 18. Global Top Neurologic Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurologic Disorders Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Neurologic Disorders Therapeutics Revenue in 2020
Figure 20. Global Neurologic Disorders Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Neurologic Disorders Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Neurologic Disorders Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Neurologic Disorders Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Neurologic Disorders Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Neurologic Disorders Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Neurologic Disorders Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Neurologic Disorders Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Neurologic Disorders Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Neurologic Disorders Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Neurologic Disorders Therapeutics Market Share by Region (2016-2027)
Figure 42. China Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Neurologic Disorders Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Neurologic Disorders Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Neurologic Disorders Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Neurologic Disorders Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Neurologic Disorders Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Neurologic Disorders Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Neurologic Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Biogen Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2016-2021)
Figure 62. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2016-2021)
Figure 63. Johnson & Johnson Services Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2016-2021)
Figure 64. Novartis AG Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2016-2021)
Figure 65. Pfizer Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---